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Abstract Using activity measurements and Western blotting, 
we demonstrated that PKCa is constitutively present in nuclei of 
Neuro-2a neuroblastoma cells. Confocal microscopy revealed 
that PKCa is present in the nucleoplasm and that this 
localization does not change after stimulation with phorbol ester. 
However, as revealed by extraction experiments, phorbol ester 
leads to a firmer association of PKCa with nuclear components. 
Our findings suggest that PKCa not only associates with lipids 
but also with proteins inside the nucleus. The presence of active 
PKCa inside the nucleus allows the enzyme to phosphorylate not 
only proteins at the nuclear envelope but also proteins in the 
nucleoplasm. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The members of the protein kinase C (PKC) family are 
involved in the transduction of a wide variety of cellular sig-
nals [1,2]. Besides its role in short-term events, such as the 
regulation of receptors or ion channels by phosphorylation, 
PKC isoforms play a pivotal role in the regulation of prolif-
eration and differentiation of cells [3,4]. Since these processes 
are dependent on the control of nuclear events, it is obvious 
that to enable PKC growth-regulatory actions, some signal 
must reach the nucleus after PKC activation. PKC may bring 
about the transduction of signals toward and into the cell 
nucleus by acting in the cytoplasm, e.g., by triggering a nu-
cleus-directed kinase cascade [5]. In addition, evidence has 
been accumulated over the past few years which shows that 
PKC can directly regulate nuclear processes. It can be trans-
located to the nucleus after stimulation or can be constitu-
tively present in the nucleus and activated there (for review see 
[6]). 
The presence of PKC isoforms in nuclei has been demon-
strated for a variety of cell types [6]. As each cell type appa-
rently expresses a defined set of PKC isoforms that are specif-
ically located within the cell [7], no general rule can be 
established: in different cell types, different PKC isoforms 
are found at the nucleus and in subnuclear compartments 
[6]. The mechanism by which the different isoforms are di-
rected to the nucleus and retained there is not clear. It is 
very likely that specific interactions with anchoring compo-
nents of the respective nuclear compartment are necessary 
to achieve the observed distribution. Several reports exist on 
the interaction of PKC with cytoplasmic components like the 
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cytoskeleton [8] and with PKC-binding proteins [9-11], but 
little is known about the association of PKC isoforms with 
nuclear components. 
In this study we show that PKCa is present in the nuclei of 
Neuro-2a neuroblastoma cells and that stimulation of these 
cells leads to a more stable association of PKCa with struc-
tures inside the nucleus. 
2. Materials and methods 
2.1. Materials 
DMEM, fetal calf serum and penicillin/streptomycin were from 
GIBCO-BRL. P81 ion-exchange-chromatography paper and DEAE-
cellulose (DE 52) were from Whatman. [y-32P]ATP was from NEN. 
Phorbol-12 myristate, 13 acetate (PMA), dibutyryl-cAMP and other 
chemicals were from Sigma. Peptide GS, a specific substrate peptide 
for PKC, derived from glycogen synthase [12], was from Bachem, 
Heidelberg. 
The monoclonal antibodies against PKCa were from UBI, the 
monoclonal antibody against neural cell adhesion molecule (N-
CAM) was from Boehringer, Mannheim. The monoclonal antibody 
against a nuclear pore complex protein used in this study was raised 
in rat against a nuclear envelope preparation. It shows exactly the 
same staining pattern as a monoclonal antibody that is directed 
against a nuclear pore complex protein and will be described else-
where in detail (manuscript in preparation). 
2.2. Cell culture and stimulation 
Mouse neuroblastoma cells (Neuro-2a) were cultured in Dulbecco's 
modified Eagle's medium containing 10% fetal calf serum, 100 ug/ml 
streptomycin and 100 U/ml penicillin at 37°C in a humidified atmos-
phere with 5% C02. 
PMA, dissolved in DMSO, was added to the medium to a final 
concentration of 160 nM. The final concentration of DMSO was 
0.06%. Stimulation was carried out for 30 min unless stated otherwise. 
2.3. Isolation of nuclei 
Isolation of nuclei was performed essentially as described earlier 
[13]. The cells were washed twice with ice-cold PBS. The cells were 
then scraped off in PBS and spun down at 500 X g for 5 min at 4°C. 
The cell pellet was resuspended in STM 0.25 (50 mM Tris-HCl, pH 
7.4. 0.25 M sucrose, 5 mM MgS04, 2 mM dithioerythritol (DTE), 10 
ug/ml leupeptin, 1 mM phenylmethylsulfonyl fluoride (PMSF)). 
Unless otherwise noted, the following manipulations were per-
formed either with ice-cold reagents or at 4°C. A solution of 10% 
Nonidet P-40 was added to a final concentration of 0.025%. The 
pellets were homogenized with 30 strokes in a glass-glass Dounce-
homogenizer (S-type). The homogenate was adjusted to 1.4 M sucrose 
by addition of an appropriate volume of STM 2.1 (50 mM Tris-HCl, 
pH 7.4, 2.1 M sucrose, 5 mM MgS04, 2 mM DTE, 10 ug/ml leupep-
tin, 1 mM PMSF). Ten milliliters of this suspension were transferred 
to each centrifuge tube and cushioned between 1 ml of STM 2.1 and 
2 ml of STM 0.8 (50 mM Tris-HCl, pH 7.4, 0.8 M sucrose, 5 mM 
MgS04. 2 mM DTE, 10 ug/ml leupeptin, 1 mM PMSF). The tubes 
were filled to 14 ml with STM 0.25 and centrifuged at lOOOOOXg for 
65 min in a swinging bucket rotor. The pellets containing the nuclei 
were resuspended in a small volume of STM 0.25. 
2.4. Preparation of plasma membranes 
A plasma membrane fraction was obtained from the interface be-
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tween 1.4 M and 0.8 M sucrose of the gradient described above. The 
material was carefully removed from the phase border and diluted 
with 4 vol. of STM 0.25. The membranes were sedimented at 
5000 Xg for 20 min and the pellets resuspended in STM 0.25. 
2.5. Extraction of nuclei 
For extraction with EDTA/EGTA, aliquots of stock solutions were 
added to suspensions of nuclei to final concentrations of 10 mM 
EGTA and 2 mM EDTA. After incubation on ice for 30 min with 
repeated mixing, nuclei were centrifuged for 15 min at lOOOXg at 4°C. 
The pellets were resuspended in STM 0.25. NP-40 was added to a 
final concentration of 1%. After 30 min incubation on ice, nuclei 
were centrifuged as described above. Proteins in the EDTA/EGTA 
extracts and the NP-40 extracts were precipitated with 10% trichloro-
acetic acid (TCA) prior to solubilization in SDS-PAGE sample buffer. 
The pellets remaining after the NP-40 extraction were directly solubi-
lized in sample buffer. To remove interfering DNA, these samples 
were mixed with 2 ui benzonase® (Merck, Darmstadt), incubated 
for 5 min at room temperature and then boiled for 5 min. 
2.6. Western blotting 
Subcellular fractions were subjected to SDS-PAGE (10% polyacryl-
amide gels) and transferred to nitrocellulose membranes. Proteins 
were stained with Ponceau red to control the efficiency of blotting 
and equal loading of the gel. The membranes were then blocked for 
2 h with a solution of 10% (w/v) nonfat dry milk dissolved in TBS-T 
(20 mM Tris, pH 7.4, 150 mM NaCl, 0.1% (v/v) Tween-20). Incuba-
tion with the primary antibody was performed for 2 h at room tem-
perature or at 4°C overnight, followed by 3 washes with TBS-T and 
incubation with the secondary antibody. Finally, blot membranes 
were washed 3 times with TBS-T and once with TBS. Colour develop-
ment with alkaline phosphatase-coupled secondary antibody was per-
formed using nitro blue tetrazolium and 5-bromo-4-chloro-3-indolyl 
phosphate (p-toluidine salt). Horseradish peroxidase-coupled antibod-
ies were detected with the ECL system (Amersham) according to the 
supplier's instructions. 
All antibodies were diluted with TBS containing 5% (w/v) nonfat 
dry milk and (with the exception of horseradish peroxidase-coupled 
antibodies) 0.02% NaN3. 
2.7. Determination of PKC activity 
Aliquots of nuclei were extracted with 1% NP-40 for 30 min on ice 
and then centrifuged for 15 min at lOOOOXg at 4°C. The supernatants 
were applied to small DEAE anion exchange columns (bed vol. 0.5 
ml) equilibrated with buffer A (20 mM Tris-HCl, pH 7.4, 1 mM 
EDTA, 1 mM EGTA, 1 mM DTE, 1 mM PMSF, 10 ug/ml leupep-
tin). After washing the columns with 2.5 ml of buffer A, PKC was 
eluted with 1.5 ml of 100 mM NaCl in buffer A. The eluates were 
concentrated in Centricon 30 microconcentrators (Amicon, Witten). 
Aliquots of the concentrated eluates were used to determination of 
PKC activity in a filter binding assay. The reaction mixture (total 
volume 50 ul) contained 20 mM triethanolamine, pH 7.4, 4 mM 
Mg-acetate, 0.1 mM CaCl2, 400 |xg/ml histone HIIIS or 50 |xM pep-
tide GS, 50 mM mercaptoethanol, 20 U.M ATP supplemented with 
[y-32P]ATP to give an activity of 6-8 X106 cpm/ml and, for assays 
under stimulating conditions, 50 |i,g/ml phosphatidylserine and 5 u.g/ 
ml diolein. After an incubation at 30°C for 10 min, 40 |xl of the 
incubation mixture was applied to P81 ion exchange filters. The filters 
were washed 3 times with 0.5% phosphoric acid. Radioactivity was 
determined by measuring Cerenkov-radiation in water. 
2.8. Immunofluorescence microscopy 
Immunofluorescence microscopy was carried out as described in 
detail elsewhere [14]. In short, Neuro-2a neuroblastoma cells were 
cultured on multiwell microscope slides (Dunn). For stimulation, cells 
were treated with 160 nM PMA (phorbol-12-myristate-13-acetate) for 
30 min. Cells were fixed with 3.7% paraformaldehyde for 10 min 
followed by permeabilization with 0.3% Triton X-100 in PBS for 10 
min. After quenching with 100 mM glycine and blocking with 1% 
BSA in PBS, cells were incubated with the first and the second anti-
body (FITC- or Texas-Red-conjugated) for 60 min at room temper-
ature in each case. Coverslips were mounted on slides with Fluoro-
mount-G (Serva). For conventional fluorescence microscopy a Leitz 
DMIRB inverted microscope (Leica) was used. Optical sections of the 
immunostained cells were obtained with confocal laser scanning mi-
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croscopy (MRC-600, Bio-Rad, coupled to an inverted Nikon Diaphot 
microscope or Leica TCS 4D, coupled to a Leica RBE microscope). 
3. Results and discussion 
3.1. Characterization of isolated nuclei 
As shown before, nuclei prepared from Neuro-2a cells ap-
peared to be intact and devoid of visible cytoplasmic struc-
tures attached to them [13]. Characterization of the nuclear 
preparation by measuring marker enzyme activities and by 
Western blot analysis of marker proteins further demon-
strated a very small degree of contamination with proteins 
of other subcellular compartments. Lactate dehydrogenase-ac-
tivity (marker for cytosol) and cytochrome c oxidase activity 
(marker for mitochondria) were not detectable with 100 |a,g of 
nuclear protein applied in the respective enzyme assays. The 
degree of contamination with plasma membrane proteins was 
checked using a monoclonal antibody against N-CAM, a pro-
tein specific for the plasma membrane. Whereas a strong sig-
nal was obtained for the plasma membrane fraction, faint 
signals were visible for the homogenate and no signals were 
detectable with the nuclear fraction (Fig. 1). 
3.2. PKC-activity associated with isolated nuclei 
PKC-activity associated with nuclei was measured after 
chromatography on small ion exchange columns. Nuclear ex-
tracts from cells stimulated with PMA contained more PKC 
activity than nuclear extracts from control cells (Fig. 2a). This 
could already be seen after 5 min stimulation, but the effect 
was more pronounced after 30 min. 
Next, we addressed the question of which PKC isoforms 
were causing the measured activity. As shown by northern 
blot studies [15], Neuro-2a cells express the PKC isoforms 
a, e, 5 and £,. Using Western blotting we found strong signals 
for PKCoc and PKCe, whereas antibodies against PKC5 and 
PKC£ gave only faint signals (data not shown). Considering 
our assay conditions and the substrate used, our results 
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Fig. 1. Characterization of subcellular fractions. Western blot analy-
sis of homogenate (H), plasma membrane (PM) and nuclear (N) 
fractions with a mAb against N-CAM shows strong enrichment of 
immunoreactivity in the plasma membrane fraction and virtually no 
signal with the nuclear fraction. Thirty micrograms of protein of 
each fraction was loaded on the gel. 
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strongly suggest a classical PKC isoform as basis for the nu-
clear PKC activity. Therefore, we concentrated our further 
experiments on PKCa. 
Western blot analysis revealed that PKCa is indeed present 
in nuclei of Neuro-2a cells. Again, we found more PKCa in 
extracts from nuclei prepared from cells stimulated with PMA 
than in control extracts (Fig. 2b). Very similar results were 
obtained, when total nuclear protein (without extraction) was 
used (data not shown). Fig. 2b also shows that PKCa is 
completely extracted with 1% NP-40; after extraction no 
PKCa could be detected in the pellets. 
Whereas the activity measurements showed a 2-3-fold in-
crease, the Western blot analysis indicated a larger increase. 
This difference may be due to the rather long procedure (in-
cluding ion-exchange chromatography) necessary for the ac-
tivity measurements, which can easily lead to a partial inacti-
vation of the enzyme 
3.3. Immunocytochemistry 
Immunocytochemical analysis using a monoclonal antibody 
against PKCa confirmed our result (obtained by Western 
blotting) that PKCa is present in Neuro-2a cell nuclei (Fig. 
3a,c). To exactly demonstrate the location of the nuclei, the 
cells were also probed with a rat monoclonal antibody against 
a pore complex protein, giving the boundaries of the nucleus 
(Fig. 3b,d). 
PKCa was present in the cytoplasm and in the nucleus, 
leaving a central region within the nucleus unstained (Fig. 
3a). Since we used confocal laser scanning microscopy, we 
can be sure that the immunofluorescence signals detected in 
the nuclear regions truly reflect nuclear localization of PKCa, 
and is not caused by staining of PKC in areas above or below 
the nucleus. Furthermore, we could clearly localize PKCa 
inside the nucleus, whereas in earlier studies using conven-
tional microscopy it was not possible to unequivocally distin-
guish between nucleoplasmic and nuclear envelope staining 
[16,17]. 
In contrast to what could be expected from activity meas-
urements and Western blotting, we could not observe an in-
crease in nuclear PKCa immunoreactivity after PMA stimu-
lation (Fig. 3c). In preparations with high cell density, contact 
sites between cells especially showed a strong increase of 
PKCa after PMA stimulation, thus showing that PMA was 
active in these cells (data not shown). 
3.4. Association of PKCa with nuclear components 
At first sight, it seems that the results obtained with isolated 
nuclei are not in agreement with the immunocytochemistry 
data. In order to resolve this apparent contradiction, we car-
ried out extraction experiments and analysed the association 
of PKC within nuclei in more detail. Extraction of nuclei from 
control cells with buffers containing EDTA and EGTA re-
sulted in release of the major part of nuclear PKCa into the 
supernatant, whereas only a minor part remained associated 
with nuclear structures and could subsequently be extracted 
with NP-40 (Fig. 4). In contrast to unstimulated cells, only a 
small portion of PKCa could be extracted from nuclei of 
PMA-stimulated cells with EDTA/EGTA, whereas the major 
portion was found to be extractable with NP-40 (Fig. 4). 
Taken together, these findings suggest that in control cells 
the majority of PKC is rather weakly associated with nuclei. 
Therefore, it could have been partially lost during the isola-
tion procedure. PMA, on the other hand, led to a firmer 
association of PKCa with nuclei, therefore rendering the ma-
jority of nuclear PKC extractable only with detergent, and 
thus preventing a loss during the isolation of nuclei. 
In contrast to immunocytochemical studies on other cell 
types [18,19] we found no indications for an association of 
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Fig. 2. PKCa in isolated nuclei from Neuro-2a cells, a: PKC activity in isolated nuclei after stimulation with 160 nM PMA for 5 and 30 min, 
expressed as percentage (± SEM) of activity found in control nuclei. Equal amounts of nuclear protein were used for extraction and activity de-
terminations in each experiment. Numbers of experiments in parentheses, b: Western blot analysis with a mAb against PKCa applied to NP-
40 extracts of isolated nuclei. Equal amounts of nuclear protein (100-200 itg) were used for extractions. In each experiment the entire pellets 
and extracts, respectively, were loaded on the gel. In the case of the extracts, proteins were precipitated with TCA. The absence of signals in 
the pellets after detergent extraction demonstrates a complete extraction. Extracts of nuclei from cells stimulated with 160 nM PMA for 30 min 
contain more PKCa than extracts from nuclei of control cells. 
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Fig. 3. Subcellular distribution of PKCa in Neuro-2a cells. Double-labeling experiments with a mAb against PKCa (a,c) and a mAb against a 
nuclear pore complex protein (b,d). The confocal images show that PKCa is localized in the cytoplasm and in the nucleus in control (a) and in 
PMA-stimulated (c) cells; PMA (160 nM for 30 min) apparently induces no change of PKCa localization in these cells. Staining with an anti-
body against a nuclear pore complex protein (b,c) delineates the boundaries of the nuclear envelope. 
PKCa with ER-structures in control and PMA-stimulated 
cells. This makes it very unlikely that the results of our ex-
traction experiments on isolated nuclei may be due to con-
tamination of the nuclear fractions with ER membranes. 
Since we could detect PKC inside the nucleus by immuno-
cytochemistry, the association of PKCa with nuclear compo-
nents most likely does not only occur with the lipids of the 
nuclear envelope but also with intranuclear, proteinaceous 
components. In recent experiments involving overlay assays, 
we were indeed able to detect nuclear proteins which bind 
activated PKC (Rosenberger et al., manuscript in prepara-
tion). 
Since even conventional PKC isoforms under certain cir-
cumstances can show lipid-independent activity [20-22], it ap-
pears to be very likely that, after stimulation with PMA, PKC 
which is associated with intranuclear components, is in an 
active state. 
The presence of active PKC in the interior of the nuclei 
would not only allow phosphorylation of nucleoplasmic pro-
teins that are located near the membrane, but also of proteins 
further inside the nucleus, for example, proteins bound to 
chromatin. A couple of DNA-regulatory proteins (e.g. 
DNA-polymerases and DNA topoisomerases) and transcrip-
tion factors (e.g. Fos, Jun and CREB) have been shown to be 
substrates of PKC (for review see [6]). 
However, most of them have only been shown to be in 
vitro-substrates. Therefore, the function of nuclear PKC is 
far from clarified. To further elucidate the function of PKC 
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Fig. 4. Differential extraction of PKCa from Neuro-2a nuclei. West-
ern blot analysis with a mAb against PKCa. Whereas the major 
portion of the enzyme could be extracted from control nuclei 
( -PMA) with EDTA/EGTA, the major portion of PKCa from 
PMA-stimulated cells (+PMA) could only be recovered in a subse-
quent extraction with NP-40. Extractions were performed with equal 
amounts of nuclei (100-300 ug of protein). The extracted proteins 
were precipitated with 10% TCA prior to loading on the gel. 
localized inside the nucleus, nuclear P K C substrates must be 
identified in intact cells and assigned a role in the context of a 
defined biological process. 
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